Last updated: July 10, 2023
Sponsor: National Taiwan University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dizzy/fainting Spells
Low Blood Pressure (Hypotension)
Treatment
Diphenhydramine
Sodium Bicarbonate
Diphenhydramine + Sodium Bicarbonate
Clinical Study ID
NCT05676216
202209092MIND
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with acute onset vertigo
Exclusion
Exclusion Criteria:
- Pregnancy
- First vertigo episode over 24 hours
- Using any anti-vertigo medicine after onset
- Drug allergy to Sodium bicarbonate or Diphenhydramine
- Diagnosed with central vertigo
- Heart failure NYHA class >1
- Chronic kidney disease (CKD) stage ≥ 3
Study Design
Total Participants: 225
Treatment Group(s): 3
Primary Treatment: Diphenhydramine
Phase:
Study Start date:
January 07, 2023
Estimated Completion Date:
December 31, 2024
Connect with a study center
National Taiwan University Yunlin Branch
Yunlin County,
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.